HomeEntertainmentAnalysis-AstraZeneca ’magic’ faces rare test after trial failure, share slide Analysis-AstraZeneca ’magic’ faces rare test after trial failure, share slide July 24, 2026byadmin Analysis-AstraZeneca ’magic’ faces rare test after trial failure, share slide Source link
Corcept president Sean Maduck sells $2.86m in stock Corcept president Sean Maduck sells $2.86m in stock Source link
Switzerland votes on proposal to cap population at 10 million Switzerland votes on proposal to cap population at 10 million Source link